Comparative Outcomes of Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients With Lower Stroke Risk
Patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc < 3 had lower complications and hospitalization costs after LAAO device implantation. These data, if redemonstrated in a large randomized trial, can have important clinical implications for stroke prevention in AF patients.
Authors
- Zain Ul Abideen Asad (ORCID: https://orcid.org/0000-0003-3110-7049)
- Muhammad Usman Khan (ORCID: https://orcid.org/0000-0003-1900-8136)
- Amanda Nguyen (ORCID: https://orcid.org/0000-0001-6256-6825)
- Samrina Khan
- Karthik Gonuguntla (ORCID: https://orcid.org/0000-0002-5607-7993)
- Sudarshan Balla
- Melody Mendez
- Muhammad Zia Khan
- Waleed Alruwaili
- Muhammad Bilal (ORCID: https://orcid.org/0009-0002-4400-2350)
- Douglas Darden
- Siddharth Agarwal
- Muhammad Bilal Munir
- Salman Zahid
Institutions
- West Virginia University (US)
- Deborah Heart and Lung Center (US)
- Heart Rhythm Society (US)
- Oregon Health & Science University (US)
- Khyber Medical University (PK)
- Oklahoma City University (US)
- West Virginia University Hospitals (US)
- University of Oklahoma Medical Center (US)
- Jacksonville University (US)
- Hattiesburg Clinic (US)
- University of California Davis Medical Center (US)
- University of Oklahoma Health Sciences Center (US)
- University of California, Davis (US)
- University of Oklahoma (US)
Publication Details
- Journal
- Pacing and Clinical Electrophysiology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1111/pace.70184
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00